Outlook Therapeutics, Inc. — All Filings
777 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
25-NSE
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POS EX
PRE 14A
PRER14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF ACTION
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 424B3 | 424B3 | 0001104659-25-048597 | May 14, 2025 | — |
| 424B3 | 424B3 | 0001104659-25-048599 | May 14, 2025 | — |
| 8-K | 8-K | 0001558370-25-004726 | Apr 11, 2025 | Apr 9, 2025 |
| SCHEDULE 13G/A | — | 0001178913-25-001278 | Apr 10, 2025 | — |
| 8-K | 8-K | 0001558370-25-004606 | Apr 8, 2025 | — |
| EFFECT | — | 9999999995-25-000844 | Mar 28, 2025 | — |
| 424B3 | 424B3 | 0001104659-25-029421 | Mar 28, 2025 | — |
| CORRESP | — | 0001104659-25-028312 | Mar 26, 2025 | — |
| UPLOAD | — | 0000000000-25-003266 | Mar 26, 2025 | — |
| S-3 | FORM S-3 | 0001104659-25-026230 | Mar 20, 2025 | — |
| 8-K | 8-K | 0001558370-25-003013 | Mar 14, 2025 | Mar 11, 2025 |
| 4/A | — | 0000947871-25-000306 | Mar 12, 2025 | Jan 17, 2025 |
| SCHEDULE 13D/A | — | 0000947871-25-000307 | Mar 12, 2025 | — |
| EFFECT | — | 9999999995-25-000616 | Mar 7, 2025 | — |
| 424B3 | 424B3 | 0001104659-25-021749 | Mar 7, 2025 | — |
| CORRESP | — | 0001558370-25-002216 | Mar 5, 2025 | — |
| UPLOAD | — | 0000000000-25-002399 | Mar 4, 2025 | — |
| SCHEDULE 13G | — | 0001178913-25-000668 | Mar 3, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-018717 | Feb 28, 2025 | — |
| S-3 | FORM S-3 | 0001104659-25-019184 | Feb 28, 2025 | — |
| 10-Q | 10-Q | 0001558370-25-001022 | Feb 14, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | — | 0001214659-25-002807 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-001205 | Feb 14, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-013509 | Feb 14, 2025 | — |
| DEF 14A | FORM DEF 14A | 0001104659-25-010946 | Feb 10, 2025 | Mar 11, 2025 |
| ARS | ARS | 0001104659-25-010947 | Feb 10, 2025 | Sep 30, 2024 |
| 4 | — | 0001415889-25-003258 | Feb 6, 2025 | Feb 4, 2025 |
| 8-K | FORM 8-K | 0001104659-25-008146 | Jan 31, 2025 | Jan 30, 2025 |
| PRE 14A | FORM PRE 14A | 0001104659-25-008169 | Jan 31, 2025 | — |
| D | — | 0001231919-25-000018 | Jan 27, 2025 | — |
| 10-K/A | 10-K/A | 0001558370-25-000366 | Jan 23, 2025 | Sep 30, 2024 |
| 4 | — | 0000947871-25-000062 | Jan 22, 2025 | Jan 17, 2024 |
| SCHEDULE 13D/A | — | 0000947871-25-000063 | Jan 22, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-004159 | Jan 16, 2025 | — |
| 10-K | 10-K | 0001558370-24-016491 | Dec 27, 2024 | Sep 30, 2024 |
| 8-K | FORM 8-K | 0001104659-24-131957 | Dec 27, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-128901 | Dec 16, 2024 | Dec 10, 2024 |
| 8-K | FORM 8-K | 0001104659-24-125350 | Dec 4, 2024 | Dec 3, 2024 |
| 8-K | FORM 8-K | 0001104659-24-123554 | Nov 27, 2024 | — |
| SC 13G/A | — | 0001172661-24-005300 | Nov 14, 2024 | — |
| SC 13G/A | AMENDMENT NO. 1 TO THE SCHEDULE 13G | 0000921895-24-002509 | Nov 7, 2024 | — |
| 4 | — | 0001415889-24-024702 | Oct 3, 2024 | Oct 1, 2024 |
| 4 | — | 0001415889-24-024701 | Oct 3, 2024 | Oct 1, 2024 |
| 4 | — | 0001415889-24-024703 | Oct 3, 2024 | Oct 1, 2024 |
| 4 | — | 0001415889-24-024704 | Oct 3, 2024 | Oct 1, 2024 |
| 4 | — | 0001415889-24-024711 | Oct 3, 2024 | Oct 1, 2024 |
| 4 | — | 0001415889-24-024706 | Oct 3, 2024 | Oct 1, 2024 |
| 4 | — | 0001415889-24-024707 | Oct 3, 2024 | Oct 1, 2024 |
| 4 | — | 0001415889-24-024708 | Oct 3, 2024 | Oct 1, 2024 |
| 4 | — | 0001415889-24-024093 | Sep 30, 2024 | Sep 26, 2024 |